M J Keating - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M J Keating

Showing results (401-410 of 436) with videos related to

Pageof 44

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.

Leukemia & Lymphoma|May 16, 2000

Progressive multifocal leukoencephalopathy with concurrent Richter's syndromeE D Saad, D A Thomas, S O'Brien, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.

Blood|May 1, 1990

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factorE H Estey, D Dixon, H M Kantarjian, et al.

Leukemia|February 25, 2012

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.

Blood|December 1, 1985

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002

Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.

Blood|February 15, 1992

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.

Blood|May 15, 1993

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemiaS M Escudier, J M Pereira-Leahy, J W Drach, et al.

Pageof 44

Search research articles

Showing results (401-410 of 436) with videos related to

Sort By:

Pageof 44

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.

Leukemia & Lymphoma|May 16, 2000

Progressive multifocal leukoencephalopathy with concurrent Richter's syndromeE D Saad, D A Thomas, S O'Brien, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.

Blood|May 1, 1990

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factorE H Estey, D Dixon, H M Kantarjian, et al.

Leukemia|February 25, 2012

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.

Blood|December 1, 1985

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002

Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.

Blood|February 15, 1992

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.

Blood|May 15, 1993

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemiaS M Escudier, J M Pereira-Leahy, J W Drach, et al.

Pageof 44